The major response of metastatic kidney cancer to the combination of oxaliplatin, 5-fluorouracil and folinic acid (FOX-FOL)
Chauffert, B.; Bonnotte, B.; Chvetzoff, G.; Flesch, M.
Presse Medicale 27(18): 859
1998
ISSN/ISBN: 0755-4982 PMID: 9767871 Document Number: 490082
Document emailed within 1 workday
Related Documents
Klaassen, U.; Harstrick, A.; Wilke, H.; Seeber, S. 1996: Preclinical and clinical study results of the combination of paclitaxel and 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer Seminars in Oncology 23(1 Suppl 1: 44-47Lu, J.-w.; Zhou, Z.-f.; Yin, B.-j.; Liu, D.-l.; Feng, J.-f.; Zhu, L.-j.; Pan, L.-x. 2005: Chronomodulated chemotherapy of oxaliplatin, 5-fluorouracil and folinic acid for advanced gastric cancer Zhonghua Zhong Liu Za Zhi 27(11): 695-697
Neyns, B.; Van Nieuwenhove, Y.; Aerts, M.; Fontaine, C.; Vermeij, J.; Schallier, D.; Decoster, L.; De Mey, J.; Vandenbroucke, F.; Hoorens, A.; Delvaux, G.; De Gréve, J. 2006: Hepatic arterial infusion of oxaliplatin and L-folinic acid-modulated 5-fluorouracil for colorectal cancer liver metastases Anticancer Research 26(1b): 611-619
Schumacher, K. 2000: Comparison of fluorouracil + folinic acid, fluorouracil + levamisole and fluorouracil + folinic acid + levamisole in Dukes' B and C colon cancer: NSABP Trial C-04 Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 176(5): 239-240
Slee, P.H.T.J.; Rodenburg, C.J.; Nortier, J.W.R.; van Bochove, A. 2004: A phase i dose-escalating study of docetaxel plus folinic acid and 5-fluorouracil in anthracycline-pretreated patients with metastatic breast cancer Netherlands Journal of Medicine 62(9): 314-319
Kalofonos, H.P.; Papakostas, P.; Makatsoris, T.; Papamichael, D.; Vourli, G.; Xanthakis, I.; Aravantinos, G.; Papadimitriou, C.; Pentheroudakis, G.; Varthalitis, I.; Samelis, G.; Syrigos, K.N.; Xiros, N.; Stavropoulos, M.; Kosmidis, P.; Christodoulou, C.; Linardou, H.; Skondra, M.; Pectasides, D.; Economopoulos, T.; Fountzilas, G. 2010: Irinotecan/fluorouracil/leucovorin or the same regimen followed by oxaliplatin/fluorouracil/leucovorin in metastatic colorectal cancer Anticancer Research 30(10): 4325-4333
Grem, J.L.; Hoth, D.F.; Hamilton, J.M.; King, S.A.; Leyland-Jones, B. 1987: Overview of current status and future direction of clinical trials with 5-fluorouracil in combination with folinic acid Cancer Treatment Reports 71(12): 1249-1264
Ohtani, H.; Arimoto, Y.; Nishio, K.; Kanamiya, Y.; Oba, H.; Adachi, K.; Shintani, M.; Nakamura, R.; Yui, S. 2008: Efficacy and toxicity of fluorouracil, leucovorin plus oxaliplatin (FOLFOX4 and modified FOLFOX6) followed by fluorouracil, leucovorin plus irinotecan(FOLFIRI)for advanced or metastatic colorectal cancer--case studies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(10): 1769-1774
Natoli, C.; Scognamiglio, M.T.; Martino, M.T.; Irtelli, L.; De Tursi, M.; Cianchetti, E.; Mascitelli, E.; Tinari, N.; Iacobelli, S. 2000: Chronomodulated infusion of cisplatin, 5-fluorouracil and folinic acid: lack of activity in advanced colorectal cancer Anticancer Research 20(2b): 1253-1256
Hiddemann, W.; Ruelfs, C.; Ottensmeier, C.; Rückle, H.; Musch, E.; Koch, O.; van de Loo, J. 1992: Interleukin-2 followed by fluorouracil and folinic acid in refractory colorectal cancer--results of a clinical phase Ii study Seminars in Oncology 19(2 Suppl 3: 225-227
Tsujie, M.; Fujiwara, S.; Kida, H.; Hayashi, N.; Fukuchi, S.; Yoshida, T.; Ebisui, C.; Sakita, I.; Hasuike, Y.; Fujimoto, T. 2005: A case of metastatic colon cancer treated with oxaliplatin combination chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(11): 1774-1775
Tsavaris, N.; Zinelis, A.; Karvounis, N.; Beldecos, D.; Mylonacis, N.; Zamanis, N.; Bacoyannis, C.; Valilis, P.; Antonopoulos, A.; Kosmidis, P. 1990: Multimodal biochemical modulation of 5-fluorouracil activity in advanced colorectal cancer with allopurinol, folinic acid and dipyridamol Journal of Chemotherapy 2(2): 123-126
Colucci, G.; Maiello, E.; Leo, S.; Giuliani, F.; Pedicini, A.; Pezzella, G.; Valori, V.; Galetta, D.; Contillo, A.; Prete, F. 1994: Biochemical modulation of fluorouracil with high dose methotrexate or folinic acid in advanced colorectal cancer patients. Gruppo Oncologico dell' Italia Meridionale (GOIM) Anticancer Research 14(5b): 2157-2162
Maoleekoonpairoj, S. 1995: Combination 5-fluorouracil (5-FU) and alpha interferon (IFN) in metastatic colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(Suppl 3): 285
Hudes, G.R.; Comis, R.L. 1988: Phase 1 and 2 studies of trimetrexate administered in combination with fluorouracil to patients with metastatic cancer Seminars in Oncology 15(2 Suppl 2: 41-45
Laudani, A.; Gebbia, V.; Leonardi, V.; Savio, G.; Borsellino, N.; Cusimano, M.Pia.; Calabria, C.; Stefano, R.; Agostara, B. 2004: Activity and toxicity of oxaliplatin plus raltitrexed in 5-fluorouracil refractory metastatic colorectal adeno-carcinoma Anticancer Research 24(2c): 1139-1142
Yamaguchi, Y.; Minami, K.; Kawabuchi, Y.; Emi, M. 2006: A phase I trial of CPT-11 in combination with 5-fluorouracil plus leucovorin chemotherapy for patients with metastatic colorectal cancer Hepato-Gastroenterology 53(68): 201-205
Khayat, D.; Gil-Delgado, M.; Antoine, E.C.; Coeffic, D.; Benhammouda, A.; Grapin, J.P.; Bastian, G. 1998: European experience with irinotecan plus fluorouracil/folinic acid or mitomycin Oncology 12(8 Suppl. 6): 64-67
Bernhard, H.; Klein, O.; Meyer zum Büschenfelde, K.H.; Knuth, A. 1992: Treatment of refractory colorectal carcinomas with fluorouracil, folinic acid, and interferon alfa-2a Seminars in Oncology 19(2 Suppl 3: 204-207
Najam, R.; Bano, N.; Mirza, T.; Hassan, S. 2014: Adverse effects on cardiovascular status and lipid levels of albino Wistar rats treated with cisplatin and oxaliplatin in combination with 5 Fluorouracil Pakistan Journal of Pharmaceutical Sciences 27(Special Issue 5): 1409-1418